IeDEA Asia-Pacific is a research program studying the treatment outcomes of over 100,000 children, adolescents, and adults living with human immunodeficiency virus (HIV) and initiating antiretroviral therapy (ART) in care and treatment facilities across several countries in Asia and the Pacific: Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. Data is based primarily on medical records obtained as part of routine patient care.
Study design
Cohort - clinical
Number of participants at first data collection
107,000 (participants)
Recruitment is ongoing
Age at first data collection
Varied (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Countries
Year of first data collection
2006
Primary Institutions
University of New South Wales (UNSW) (Academic, Australia)
amfAR, The Foundation for AIDS Research (Third Sector, Thailand)
Profile paper DOI
Not available
Funders
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (Government, United States of America)
Fogarty International Center (FIC) (Government, United States of America)
National Cancer Institute (NCI) (Government, United States of America)
National Heart, Lung, and Blood Institute (NHLBI) (Government, United States of America)
National Institute of Allergy and Infectious Diseases (NIAID) (Government, United States of America)
Ongoing?
Yes
Data types collected



Engagement
Keywords
Consortia and dataset groups